Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,248,023 papers from all fields of science
Search
Sign In
Create Free Account
Delavirdine Mesylate
Known as:
Delavirdine Mesylate [Chemical/Ingredient]
, Mesylate, Delavirdine
A mesylate salt form of delavirdine, a synthetic, non-nucleoside reverse transcriptase inhibitor. In combination with other anti-retroviral drugs…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Acquired Immunodeficiency Syndrome
Alprazolam
Astemizole
Cisapride
Expand
Broader (3)
Delavirdine
Indoles
Piperazines
Narrower (2)
Rescriptor
U-90152
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Determination of the Composition of Delavirdine Mesylate Polymorph and Pseudopolymorph Mixtures Using 13C CP/MAS NMR
P. Gao
Pharmaceutical Research
2004
Corpus ID: 6122113
AbstractPurpose. The application of solid-state nuclear magnetic resonance for the quantitation of relative amounts of…
Expand
Review
2002
Review
2002
Rifampin and rifabutin drug interactions: an update.
C. Finch
,
C. R. Chrisman
,
A. M. Baciewicz
,
T. Self
Archives of internal medicine
2002
Corpus ID: 24382628
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of well-documented clinically significant…
Expand
1999
1999
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3…
G. Friedland
,
R. Pollard
,
+9 authors
M. Fischl
1999
Corpus ID: 76300699
To evaluate the antiretroviral activity of delavirdine mesylate, a non-nucleoside reverse transcriptase inhibitor of HIV-1, we…
Expand
Highly Cited
1998
Highly Cited
1998
Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
R. Voorman
,
S. M. Maio
,
N. A. Payne
,
Z. Zhao
,
K. Koeplinger
,
X. Wang
The Journal of pharmacology and experimental…
1998
Corpus ID: 19346016
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic…
Expand
1998
1998
Pharmacokinetic drug-drug interaction study of delavirdine and indinavir in healthy volunteers.
J. Ferry
,
B. D. Herman
,
B. J. Carel
,
G. Carlson
,
D. Batts
Journal of acquired immune deficiency syndromes…
1998
Corpus ID: 20471611
The potential pharmacokinetic drug-drug interaction between delavirdine, a nonnucleoside analogue reverse transcriptase inhibitor…
Expand
Highly Cited
1997
Highly Cited
1997
Steady‐state pharmacokinetics of delavirdine in HIV‐positive patients: Effect on erythromycin breath test
C. Cheng
,
D. E. Smith
,
+7 authors
P. Stetson
Clinical pharmacology and therapeutics
1997
Corpus ID: 34122850
1997
1997
Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection
G. Morse
,
M. Fischl
,
+4 authors
W. Freimuth
Antimicrobial agents and chemotherapy
1997
Corpus ID: 24869338
Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1…
Expand
Highly Cited
1997
Highly Cited
1997
Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate
M. Borin
,
J. H. Chambers
,
B. J. Carel
,
S. Gagnon
,
W. Freimuth
Clinical pharmacology and therapeutics
1997
Corpus ID: 2135771
Review
1996
Review
1996
Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
W. Freimuth
Advances in experimental medicine and biology
1996
Corpus ID: 44512677
In summary, DLV has been well-tolerated in > 1,000 HIV-1 infected patients. Skin rash is the most prevalent medical event…
Expand
Highly Cited
1996
Highly Cited
1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients
R. Davey
,
D. Chaitt
,
+15 authors
H. Lane
Antimicrobial agents and chemotherapy
1996
Corpus ID: 25864728
Delavirdine mesylate (DLV) is a potent nonnucleoside reverse transcriptase inhibitor with activity specific for human…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE